Jasper Therapeutics Inc (JSPR) — Cash Flow Quality Index

Latest as of March 2020: -0.16x

Jasper Therapeutics Inc (JSPR) has a Cash Flow Quality Index of -0.16x as of March 2020. Operating cash flow of $-232.87K is below net income of $1.43 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Jasper Therapeutics Inc (JSPR) cash flow conversion to assess how effectively this company generates cash.

Cash Flow Quality Index

-0.16x

Operating CF / Net Income

Operating Cash Flow

$-232.87K

USD

Net Income

$1.43 Million

USD

Data as of

Mar 2020

Most recent filing

Annual Cash Flow Quality Index for Jasper Therapeutics Inc (None–None)

Year-by-year earnings quality comparison for Jasper Therapeutics Inc. For live market cap and the full company financial profile, see Jasper Therapeutics Inc market cap and net worth.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.